The Scientist

» BRCA2

Most Recent

With three recent FDA approvals, and a number of Phase 3 trials ongoing, the drugs are seeing a surge in interest.

0 Comments

The agency gave personal genomics company 23andMe the green light to screen samples for breast cancer–related genetic mutations.

0 Comments

image: Genetic Risk Factors for Breast Cancer Identified

Genetic Risk Factors for Breast Cancer Identified

By Ashley P. Taylor | October 23, 2017

Researchers identify 72 novel genetic variants associated with breast cancer risk.

0 Comments

image: Q&A: Sequencing Newborns

Q&A: Sequencing Newborns

By Tracy Vence | October 21, 2016

Members of the BabySeq Project discuss trial enrollment, preliminary findings.

1 Comment

image: BRCA Breakthroughs?

BRCA Breakthroughs?

By Jenny Rood | April 21, 2015

Color Genomics announces a new, lower-cost BRCA mutation test, while Inserm and Quest Diagnostics reveal plans to pool patient data to investigate rare mutations.

0 Comments

image: <em>BRCA</em> Mutations Mapped

BRCA Mutations Mapped

By Tracy Vence | April 7, 2015

In a large study, researchers find evidence to suggest that the type and location of a woman’s BRCA1/2 mutations may affect her cancer risk.

0 Comments

image: Yet Another Lawsuit over Genetic Tests

Yet Another Lawsuit over Genetic Tests

By Tracy Vence | June 17, 2014

Myriad Genetics, the company originally behind tests for the cancer-associated BRCA mutations, is suing another competitor for patent infringement.

0 Comments

image: Speaking of Science

Speaking of Science

By The Scientist Staff | August 1, 2013

August 2013's selection of notable quotes

0 Comments

image: Another Lawsuit over Genetic Tests

Another Lawsuit over Genetic Tests

By Kate Yandell | July 11, 2013

Myriad Genetics, the company originally behind tests for the cancer-associated BRCA mutations, is suing two competitors for patent infringement.

0 Comments

image: Gene Patents Decision: Everybody Wins

Gene Patents Decision: Everybody Wins

By Jeffrey M. Perkel | June 18, 2013

Last week’s Supreme Court decision to invalidate patents on human genes was a win for patients, independent researchers, and even the wider biotech industry.

4 Comments

Popular Now

  1. Prominent Salk Institute Scientist Inder Verma Resigns
  2. Dartmouth Professor Investigated for Sexual Misconduct Retires
  3. Theranos Leaders Indicted For Fraud
    The Nutshell Theranos Leaders Indicted For Fraud

    Federal prosecutors filed criminal charges that allege the company’s promise to revolutionize blood testing swindled investors out of hundreds of millions of dollars and put patients in danger.

  4. Probiotics Prevent Cholera in Animal Models